In summary, directing further investigations to the SNPs discussed here, and deepening knowledge on how 3′UTR ERAP1 variants may alter the mechanism of action of viral miRNAs, may be useful for the development of antiviral therapies or for the treatment of complications caused by HCMV infection. This evidence concerns the gene ERAP1 and cytomegalovirus infection.